Table 4.
Organ/compartment | Condition | CVID with bronchiectasis (n = 197) | CVID w/o bronchiectasis (n = 1273) | p value |
---|---|---|---|---|
| ||||
Nasal | Allergic rhinitis (AR) | 16 (8.12) | 78 (6.13) | .28 |
Chronic rhinosinusitis (CRS) | 27 (13.71) | 98 (7.70) | .01 | |
Nasal polyps | 3 (1.52) | 7 (0.55) | .14 | |
Ear | Hearing loss | 4 (2.03) | 15 (1.18) | 0.31 |
Chronic otitis | 1 (0.51) | 13 (1.02) | 0.71 | |
Eustachian tube dysfunction | 2 (1.02) | 6 (0.47) | .29 | |
Other upper airway | Vocal cord dysfunction | 1 (0.51) | 7 (0.55) | 1.00 |
Lower airway | Chronic bronchitis | 3 (1.52) | 17 (1.34) | .74 |
COPD | 25 (12.69) | 49 (3.85) | .00 | |
Asthma | 98 (49.75) | 512 (40.22) | .01 | |
Lung alveoli | PAP | 1 (0.51) | 4 (0.31) | .51 |
ARDS | 3 (1.52) | 1 (0.08) | .01 | |
Lung Interstitium | ILD (ALL) | 32 (16.24) | 71 (5.58) | .00 |
ILD ns | 24 (12.18) | 48 (3.77) | .00 | |
OP | 4 (2.03) | 7 (0.55) | .048 | |
FIB | 4 (2.03) | 6 (0.47) | .03 | |
IP | 2 (1.02) | 8 (0.63) | .63 | |
LIP | 6 (3.05) | 11 (0.86) | .02 | |
NLH | 2 (1.02) | 3 (0.24) | .14 | |
BO | 4 (2.03) | 2 (0.16) | .00 | |
FB | 5 (2.54) | 8 (0.63) | .02 | |
Nodular lesions (ALL) | 8 (4.06) | 34 (2.67) | .26 | |
Single nodule | 1 (0.51) | 10 (0.79) | 1.00 | |
Multiple nodules | 7 (3.55) | 24 (1.89) | .18 | |
Lung granulomas | 10 (5.08) | 14 (1.10) | .00 | |
Lung vasculature | Pulmonary embolism (PE) | 2 (1.02) | 9 (0.71) | .65 |
Pulmonary arterial hypertension (PAH) | 2 (1.02) | 6 (0.47) | .29 | |
Pleura | Pleural compromise (ALL) | 11 (5.58) | 26 (2.04) | .01 |
Empyema | 1 (0.51) | 10 (0.79) | 1.00 | |
Pleural ns | 10 (5.08) | 17 (1.34) | .00 | |
Other | Chest Anatomy | 5 (2.54) | 18 (1.41) | .22 |
OSA | 10 (5.08) | 56 (4.40) | .71 |
This table summarizes the details of non-infectious respiratory conditions by compartment. Data are presented as frequency and percentage of patients in each group. Comparisons were made using the chi-square test. Bolding indicates statistical significance (p ≤ .05)